Chalmers J, Arima H, Harrap S, Touyz R, Park JB. Global survey of current practice in management of hypertension as reported by societies affiliated with the International Society of Hypertension. J Hypertens 2013 May;31(5):1043-8. (SCI IF; 4.07)

Park JB. Sung K-C, Kang S-M, Jou EJ. Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study): An Open-Label Observational Study. Am J CV Drugs 2013 Feb;13(1):47-56 .(SCI IF. 1.77)

Lee H, Yang HM, Lee HY, Kim JJ, Choi DJ, Seung KB, Jeon ES, Ha JW, Rim SJ, Park JB, Shin JH, Oh BH. Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies. Clin Ther. 2012 Jun;34(6):1273-89. (SCI IF; 2.321)

Sung KC, Kang SM, Cho EJ, Park JB, Wild SH, Byrne CD. Ferritin Is Independently Associated With the Presence of Coronary Artery Calcium In 12 033 Men. Arterioscler Thromb Vasc Biol. 2012Jul;32(10):2525-30. (SCI IF; 6.368)

Jae SY, Heffernan KS, Yoon ES, Park SH, Choi YH, Fernhall B, Park JB. Change in pulsatile stress is a better predictor of change in arterial stiffness than change in inflammation over time. J Atheroscler Thromb. 2012 Nov 26;19(11):1035-42 (IF, 2.84)